A long-acting GLP-1 receptor agonist given once weekly. It slows gastric emptying and acts on hypothalamic appetite signalling, and it carries the deepest clinical trial record of any peptide used for weight management.
FDA-approved (Ozempic, Wegovy, Rybelsus).
Ranges compiled from published protocols, not a clinical guideline. Convert a dose into syringe units with the dosage calculator.
This page summarises how much a compound has been studied. A high publication count is not evidence that something works, is safe, or is legal to obtain where you live. Consult a qualified healthcare provider before acting on anything here.
Our mission is to make peptide research clear, credible, and usable for people who refuse to rely on hype.